KA
CLX icon

Kovack Advisors’s Clorox CLX Stock Holding History

Kovack Advisors’s Portfolio CLX Stock Details CLX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$248K Buy
2,585
+221
+9% +$21.2K 0.01% 897
2026
Q1 		$246K Buy
2,364
+367
+18% +$41.6K 0.01% 833
2025
Q4 		$201K Buy
+1,997
New +$217K 0.01% 946
2023
Q1 		– Sell
-3,002
Closed -$421K – 616
2022
Q4 		$421K Buy
3,002
+79
+3% +$11.2K 0.06% 321
2022
Q3 		$375K Sell
2,923
-136
-4% -$19.6K 0.06% 353
2022
Q2 		$431K Sell
3,059
-380
-11% -$54.3K 0.06% 359
2022
Q1 		$478K Buy
+3,439
New +$527K 0.05% 396
2020
Q4 		– Sell
-2,495
Closed -$524K – 624
2020
Q3 		$524K Sell
2,495
-27
-1% -$6.01K 0.09% 218
2020
Q2 		$553K Sell
2,522
-1,051
-29% -$210K 0.11% 201
2020
Q1 		$619K Sell
3,573
-217
-6% -$35.9K 0.14% 159
2019
Q4 		$582K Buy
3,790
+475
+14% +$71K 0.1% 220
2019
Q3 		$503K Sell
3,315
-162
-5% -$25.6K 0.1% 230
2019
Q2 		$532K Buy
3,477
+1,375
+65% +$210K 0.12% 202
2019
Q1 		$337K Buy
+2,102
New +$326K 0.08% 267
2017
Q3 		– Sell
-1,531
Closed -$204K – 372
2017
Q2 		$204K Buy
+1,531
New +$207K 0.06% 329
2017
Q1 		– Sell
-3,298
Closed -$396K – 310
2016
Q4 		$396K Buy
+3,298
New +$389K 0.19% 130

Other funds holding CLX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $164B AUM 112.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Kovack Advisors's CLX Position: Q2 2026 in Review

Kovack Advisors increased its Clorox (CLX) stake by 9.3% in Q2 2026, buying an estimated $21.2K and bringing the position to 2,585 shares worth $248K. The position accounts for 0.01% of the portfolio, ranked #897.

Kovack Advisors first reported a position in CLX in Q4 2016 and has held it in 16 quarters since. The position peaked at $619K in Q1 2020. 1,044 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Kovack Advisors held 2,585 shares of Clorox worth $248K as of Q2 2026.
  • Kovack Advisors bought 221 Clorox shares in Q2 2026, an estimated $21.2K.
  • Clorox made up 0.01% of Kovack Advisors's portfolio in Q2 2026, its #897 holding.
  • Kovack Advisors first reported a position in Clorox in Q4 2016 and has held it in 16 quarters since.
  • Kovack Advisors's Clorox position peaked at $619K in Q1 2020.
  • 1,044 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Kovack Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.